Company: HRTX
Filing Date: 2025-10-15
Form Type: 8-K
Source: 0001193125-25-240253
Chunk: 1

Company: HERON THERAPEUTICS, INC. /DE/
Filing Date: 2025-10-15
Form: 8-K
Item: Item 5.07
Chunk 1
---
 prior to such issuance:

         For        Against      Abstain      Broker Non-Votes  
 ────────────────────────────────────────────────────────────────
  89,632,206      5,575,457      218,161                     0  

Proposal 2: The Company’s stockholders approved, pursuant to Nasdaq Listing Rule 5635(d), the issuance of a number of shares of the Company’s Common Stock in connection with the automatic conversion of the Company’s Series A Convertible Preferred Stock held by several non-affiliated holders, which could, under certain circumstances that may occur in the future, exceed 19.99% of the number of shares of the Company’s Common Stock issued and outstanding prior to such issuance:

         For        Against      Abstain      Broker Non-Votes  
 ────────────────────────────────────────────────────────────────
  91,534,602      3,672,091      219,131                     0  

Item 9.01 Financial Statements and Exhibits.